← Evidence map

ReviewBioengineered2022

Biosimilar monoclonal antibodies in China: A patent review.

Jia-Wei Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35758066